CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy,...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada CALGARY, October 20, 2023 – ATMA Journey Centers Inc. (“ATMA”),...
All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery The post Believing you took ketamine during surgery...
Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth. The post Spravato Sales Lead J&J...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
The FDA has issued a warning letter regarding the use of ketamine outside of FDA-approved conditions. The post FDA Issues Warning Letter for Ketamine...
Research has shown ketamine to have rapid antidepressant effects. The post Ketamine Clinics Hope to ‘Open New Doors’ for Patients with Severe Depression...
Spravato is the only FDA-approved version of ketamine that isn't injectable. The post FDA Issues Warning Letter On Compounded Ketamine appeared first on...